Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4737
Revised: April 12, 2013
Accepted: June 1, 2013
Published online: August 7, 2013
Core tip: Liver transplantation (LT) for hepatocellular carcinoma (HCC) is known to be the best therapeutic option. To obtain a good result, it is important to select appropriate LT candidates from among HCC patients. For living-donor liver transplantation (LDLT), investigation of the efficacy of such criteria will facilitate adoption of extended criteria in LDLT. We defined the selection criteria according to risk factors for recurrence based on our results and compared them with other criteria or scoring systems, such as the Milan and University of California, San Francisco criteria, tumor node metastasis and Barcelona Clinic Liver Cancer staging, and the Cancer of the Liver Italian Program scoring system.